Zealand Pharma wants to be world-leading within five years

Within the next half decade, Zealand Pharma aims to be one of the world leaders in treatment of rare metabolic disorders and gastrointestinal diseases. The foundation for success will be laid this year with four late-phase programs and an upcoming launch of two self-owned drugs.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles